Mesothelial cells enable rapid invasion and spread of ovarian cancer
Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the…
Tumor-targeted chimeric drug increases efficacy and limits side effects
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more…
Cholesterol transporter ABCA1 boosts macrophage-driven cancer immunity
In recent years, cancer researchers have made major breakthroughs by using the body’s immune system to fight cancer.…
RNA micelles enable targeted chemotherapy without immune toxicity
A new study in mice hints at the potential to use tiny particles made with RNA molecules to…
Biological Clocks Are a Mystery — This Class Tracks Them Down
We wake up in the morning and go to bed at night — most of us, at least.…
European collaboration transforms immune cell data into cancer biomarkers
World Cancer Day, marked on 4 February, is an international day dedicated to raising awareness of cancer, and…
Study elucidates key steps in the ubiquitin tagging of mutated huntingtin protein
Researchers have elucidated key steps in the ubiquitin tagging of the mutated huntingtin protein, providing hope for future…
Reprogrammed neutrophils promote tumor growth
Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE)…
Artificial lung keeps patient alive after lung removal
By replacing both breathing and circulatory buffering, a novel artificial lung bought critical time after lung removal, revealed…
Gut microbial butyrate enhances mucosal vaccine antibody responses
A research team from POSTECH and ImmunoBiome in Korea, led by Professor Sin-Hyeog Im, has uncovered a new…
Sub-terahertz biosensors enable label-free cancer cell identification
Early detection and accurate typing of cancer are critical for improving patient survival rates. While traditional pathology remains…
Immune scaffold predicts onset weeks early
A retrievable immune scaffold reveals a 5–7 week presymptomatic window for tracking type 1 diabetes progression, long before…